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The association of blood lead (B-Pb) concentration to blood pressure was investigated in men aged 55 to 75 years living in the Rome area, who had
no history of exposure to lead in the workplace and who participated between 1989 and 1990 in an epidemiologic survey for coronary heart disease
(New Risk Factor Project). Of the 1856 individuals eligible for the study, 59 were excluded from analyses because not all relevant data were
available; and 478 were excluded because they were treated for hypertension. In the remaining subjects (n = 1319) the median B-Pb concentration
was 113 pg/l (range: 40-442 pg/I). Systolic blood pressure (SBP) averaged 140 ± 18 (standard deviation) mm Hg (range 98-220) and diastolic blood
pressure (DBP) 84 ± 9 mm Hg (range 56-118). Median B-Pb values increased significantly from 1 1 1 pg/l in subjects with normal blood pressure (n =
668) to 1 13.5 pg/l in subjects with borderline high blood pressure (n = 373) and to 120 pg/l in subjects with increased blood pressure (n = 278). After
log-normal conversion of B-Pb, the linear correlation coefficient between ln[B-Pb(ug/l)] and both SBP and DBP was statistically significant
(r = 0.1332, p <0.001 and r = 0.0737, p = 0.007, respectively). The linear regression coefficient was 6.8 mm Hg/ln(pg/l) for SBP and 1.8 mm
Hg/ln(pg/l) for DBP. Multiple regression analyses revealed that, after correction for body mass index (BMI), age, heart rate, skinfold thickness, serum
lipids, and glucose levels, blood lead was still a significant predictor of increased SBP and DBP. The adjusted regression coefficient was 5.6 mm
HgAn(ug/l) for SBP and 1.7 mm Hg/ln(pg/l) for DBP. In further analyses subjects were divided, according to alcohol consumption, into drinkers (n =
1068) and nondrinkers (n = 251). Among nondrinkers the median B-Pb levels was 97 pg/l (2.5th and 97.5th centiles 55-181 pg/I) and SBP and DBP
averaged 138 ± 17 and 84 ± 9 mm Hg, respectively. No significant relationship between In[B-Pb] and blood pressure was found. In drinkers the
median B-Pb level was 1 17 pg/l (2.5th and 97.5th centiles: 63-252 pg/I) and SBP and DBP averaged 141 ± 18 and 84 ± 9 mm Hg, respectively. The
linear regression coefficient was 7.5 mm Hg/ln(pg/l) for SBP and 2.6 mm Hg/ln(pg/l) for DBP. In multiple stepwise regressions including BMI, age,
heart rate, smoking, skinfold thickness, serum lipids, and glucose levels as covariates-the partial correlation coefficient of systolic and diastolic
blood pressure with In[B-Pb] remained statistically significant. The adjusted regression coefficients were 5.6 mm Hg/ln(pg/l) for SBP and 2.5 mm
Hg/ln(pg/l) for DBP. These findings indicate that a slight to moderate positive relationship exists between blood pressure and blood lead concentra-
tions in male drinkers aged 55 to 75 years. -Environ Health Perspect 102(Suppl 9):107-111 (1994)
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Introduction
Low to moderate increases in blood lead
(B-Pb) concentrations, as those occurring
in subjects living in industrialized areas
even in the absence of an occupational
exposure, have been related to a small or
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moderate increase in blood pressure (1-10).
This positive relationship has not been
observed in a large survey conducted in
Wales (11).
A number of confounding factors,
whose impact has not always been ana-
lyzed, have been reported to affect the
entity of the blood pressure/B-Pb relation.
Grandjean et al. (12) observed that the
positive relationship between B-Pb and
blood pressure was no longer significant
when alcohol intake and hemoglobin were
included in a multiple regression analysis.
Staessen et al. (13) reported that the addi-
tion of gender and age as covariates to
models predicting blood pressure reduced
the partial correlations ofsystolic and dias-
tolic blood pressure with B-Pb to a nonsignifi-
cant level. Sharp et al. (6) observed that a
positive relationship between blood pres-
sure and B-Pb was present in black males
but not among nonblack males; the inclu-
sion of alcohol use indicators in multiple
regression models did not alter the relation-
ship between blood pressure and B-Pb by
more than 10%. In black subjects adjusting
for tobacco use markedly increase the asso-
ciation between B-Pb and blood pressure.
In addition, the relationship was particu-
larly strong in blacks who were infrequent
users ofcaffeine (6).
The aim of the present study was to
examine the relationship between B-Pb and
blood pressure in middle-aged and elderly
men living within the Rome area, taking
into account the potential confounding
effect of selected social and biochemical
factors associated to blood pressure and
B-Pb.
Materials and Methods
Between June 1989 and December 1990, a
total of 1856 men aged 55 to 75 years par-
ticipating in the New Risk Factors (NRF)
Survey underwent a comprehensive exami-
nation. The primary aim ofthe project was
to identify risk factors which can predict
coronary heart disease and total mortality.
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Initially between 1979 and 1981, a
total of3395 subjects were seen. They rep-
resented the 76.5% of4438 men enrolled
from four occupational groups belonging
to defined public companies or agencies
located in Rome where the screening was
offered at the worksite. At the time of the
follow-up (1989-1990) 410 subjects had
died; and of the remaining 2985 subjects,
1856 (62.2%) agreed to participate. The
examination included a medical history; a
physical examination; and measurement of
height, weight, various skinfold thick-
nesses, and blood pressure. Furthermore, a
venous blood sample was drawn after
overnight fasting.
Diseases, reported by the subjects
themselves, were coded according to the
International Classification ofDiseases
(ICD), 9th Revision.
Blood pressure measurements were per-
formed according to World Health
Organization Guidelines (14). With the
subject seated, systolic blood pressure
(SBP) and fifth phase diastolic blood pres-
sure (DBP) were measured twice in the left
arm with an ordinary sphygmomanometer
to the nearest 2 mm Hg. Increased blood
pressure was defined as a SBP at or above
160 mm Hg and/or a DBP at or above 95
mm Hg. Borderline high blood pressure
was defined as a SBP below 160 mm Hg
but above 140 mm Hg and/or a DBP
below 95 mm Hg but above 90 mm Hg.
Heart rate (HR, beats/min) was calculated
from electrocardiographic traces as an aver-
age of rates in lead I and lead V6.
Information about alcohol consumption
and smoking habits was collected for each
subject by direct interview. Alcohol con-
sumption (ALC) was calculated for wine,
beer, and spirits separately and the amount
ofalcohol intake was expressed in grams of
absolute ethanol consumed per day. Daily
cigarette consumption (CIG/D) was
recorded as a measure of tobacco use.
Height and weight were compacted into a
body mass index (BMI, kg/M2). Triceps,
biceps, subscapular, suprascapular, and
suprailiac skinfold thicknesses were mea-
sured by Harpenden calipers to the nearest
millimeter. The variable skinfold thickness
(SKF) was defined as the sum of the five
measurements.
Venous blood samples for B-Pb deter-
mination were drawn into polypropylene
tubes containing K3EDTA as anticoagu-
lant and stored at -20°C until analysis. All
the equipment used was free from lead. B-
Pb (pg/1) was measured by Atomic
Absorption Spectrophotometry (AAS)
using a Perkin-Elmer model Zeeman 5000,
HGA 500. The method for B-Pb (15)
determination has been previously
described. The analytical variability of the
method has been checked by the adoption
of appropriate internal quality controls.
Control charts were prepared with mea-
surements carried out on control samples
with certified titles, provided by the
Community Bureau of Reference, Com-
mission of the European Community.
Between-day precision, obtained from B-
Pb measurements carried out on our sub-
jects, was 2.7%. Analytic precision and
accuracy for B-Pb were also monitored by
means ofexternal quality control samples,
according to procedures previously
described (16,17). Serum levels ofcholes-
terol (CHOL, mg/dl), high-density
lipoprotein cholesterol (HDL, mg/dl),
triglycerides (TRIG, mg/dl), and glucose
(GLU, mg/dl) were determined by auto-
mated methods within 12 hr ofcollection,
the samples having been stored at +40C
until analysis. The amount of non-HDL
cholesterol (N-HDL) was calculated as the
difference between CHOL and HDL.
Subjects were excluded from the pre-
sent study when not all relevant data were
available (n = 59) or iftheywere treated for
hypertension (n = 478). After these exclu-
sions a sample of 1319 subjects was
obtained. In further analyses subjects were
divided according to alcohol consumption
in drinkers (n = 1068) and nondrinkers (n
= 251). Log-normal transformation ofthe
B-Pb approached a Gaussian distribution;
the use ofln [B-Pb] enabled us to perform
parametric analyses ofdata, i.e. linear cor-
relation and multiple stepwise regression.
All statistical analyses ofdata were carried
out using the BMDP Statistical Software
package.
Results
In the 1319 subjects the median B-Pb was
113 pg/l (2.5th-97.5th centiles: 62-247
pg/l; range 40-442 ug/l). SBP averaged
140 ± 18 (standard deviation) mm Hg
(range 98-220 mm Hg) and DBP 84 ± 9
mm Hg (range 56-118 mm Hg). The
mean age was 63 ± 5 years (range 55-75
years). BMI averaged 26.5 ± 3.2 kg/m2 and
HR 66 ± 11 beats/min. Out ofall subjects,
251 (19.0%) were nondrinkers. Among
drinkers (n = 1068) the median ethanol
intake was 18.4 g/day and more than 90%
of total alcohol intake was due to wine.
With regard to smoking habits, 72% of
subjects were nonsmokers; among current
smokers (369 subjects) the median con-
sumption was of 15 cigarettes daily
(25th-75th centiles: 8-20).
Median B-Pb levels in relation to blood
pressure categories: normal blood pressure,
n = 668; borderline blood pressure, n =
373; and increased blood pressure, n =
278, are shown in Table 1. Median B-Pb
increased significantly, (p = 0.0004), from
111 pg/l in the normal blood pressure
group to 113.5 pg/l in the borderline high
blood pressure group, and to 120 pg/l in
the increased blood pressure group. In the
same table median values ofAGE, BMI,
HR, CHOL, HDL, GLUC, CIG/D, ALC,
and SKF in relation to blood pressure cate-
gories are reported; for the variables ALC
Table 1. Median values (Mdn) of B-Pb, AGE, BMI, HR, N-HDL, HDL, TRIG, GLUC, CIG/D, ALC and SKF in relation to
blood pressure categories.
Normal blood Borderline blood Increased blood
pressure, n= 668 pressure, n= 373 pressure, n= 278
97.5th 97.5th 97.5th
Mdn centile Mdn centile Mdn centile K-W P
B-Pb 111 113.5 120 15.79 0.0004
AGE 62 64 63.5 11.52 0.0032
BMI 25.8 26.6 27.2 45.29 0.0000
HR 63 66 67.5 42.00 0.0000
N-HDL 181 191 190 13.40 0.0012
HDL 46 46.5 48 7.27 0.0264
TRIG 120 135 139.5 17.96 0.0001
GLUC 99 101 100.5 9.34 0.0094
CIG/Da 0 28 0 25 0 25 29.89 0.0000
ALCa 16 80 16 94 16 120 8.56 0.0014
SKF 53 53.5 56 9.82 0.0074
Abbreviations: B-Pb, blood lead level (pg/I); BMI, body mass index (kg/m2); HR, heart rate (beats/min);
N-HDL, non-HDL-cholesterol(mg/dl); HDL, HDL-cholesterol (mg/dl); TRIG, triglycerides (mg/dl); GLUC, glucose
(mg/dl); CIG/D, cigarettes smoked daily; ALC, alcohol consumption (g/day); SKF, skinfold thickness (mm). aFor and
CIG/D ALC, 97.5th centiles (97.5th) oftheir distributions are also given. Statistical significance was determined by
means ofthe Kruskall-Wallis test(K-W).
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Table 2. Type (+, positive; -, negative) and statistical significance of linear correlations between SBP, DBP, In[B-
Pb], and othervariables considered in the analyses (subjects = 1319).
SBP DBP Ln[B-Pb]
Type T-value Type T-value Type T-value
AGE + 5.432d _ 5.374d - 2.357b
BMI + 6.089" + 10.984" - 0.780
HR + 5.826d + 7.331 d - 0.933
N-HDL + 4.090d + 3.011c + 2.444b
HDL + 3.566d + 1.510 + 9.007d
TRIG + 2.978c + 3.048c - 2.287a
GLUC + 5.432d + 0.936 - 1.492
CIG/D - 3.166c - 5.164d + 5.389d
ALC + 4.065" + 2.744c + 14.9918
SKF + 2.305a + 6.667d - 5.157d
ap<0.05 bp<0.02 cp<0.01 dp<0.001. Abbreviations: BMI, body mass index; HR, heart rate; N-HDL, non-HDL-choles-
terol; HDL, HDL-cholesterol; TRIG, triglycerides; GLU, glucose; CIG/D, cigarettes smoked daily; ALC, alcohol con-
sumption; SKF, skinfold thickness.
and CIG/D, 97.5th centiles oftheir distri-
butions are also shown.
In the 1319 subjects the linear correla-
tion coefficients between ln[B-Pb] and
both SBP and DBP were statistically signif-
icant (r = 0.1332,p<0.001 and r = 0.0737,
p = 0.007, respectively). The linear regres-
sion coefficient was 6.8 mm Hg/ln(pg/l)
for SBP and 1.8 mm Hg/ln(jig/l) for DBP.
The entity ofthe association determined by
means of Pearson's correlation coefficient
of the other considered variables to ln[B-
Pb] and to both SBP and DBP, is reported
in Table 2. The variables ALC and N-
HDL were positively related to ln[B-Pb]
and both SBP and DBP. HDL was related
directly to ln[B-Pb] and SBP. TRIG and
SKF were related directly to SBP and DBP
and inversely to ln[B-Pb]. AGE was related
directly to SBP and inversely to both DBP
and ln[B-Pb]. CIG/D was related directly
to ln[B-Pb] and inversely to both SBP and
DBP. As some of these associations might
be a possible source ofpositive or negative
confounding bias, multivariate analyses
were performed with the aim ofestimating
the entity and the independence of the
relationship between B-Pb and blood pres-
sure. A first set ofmultiple stepwise regres-
sions analyzed SBP and DBP as dependent
variables for the 1319 subjects, with a
model including ln[B-Pb], AGE, BMI,
HR, N-HDL, HDL, TRIG, GLU, CIG/D,
ALC, and SKF as possible predictors. In
these models, 16.06 and 13.14% of DBP
and SBP, variances were explained, respec-
tively. BMI, AGE, ln[B-Pb], HR, and
HDL were the most significant predictors
for SBP, explaining 3.4, 2.8, 2.0, 1.8, and
0.8% of the total variance, respectively.
With regard to DBP the most important
predictors were BMI, HR, AGE, CIG/D,
and ln[B-Pb], which explained 8.4, 3.0,
1.7, 1.6, and 0.7% of the total variance,
respectively. The change in the regression
coefficient ofln[B-Pb(pg/l)] with successive
addition ofcovariates to the multiple step-
wise regression models predicting SBP and
DBP is showed in Figure 1; after the last
step ofthe stepwise analysis the regression
coefficients were 5.6 mm Hg/ln(pg/l) for
SBP and 1.7 mm Hg/ln(pg/l) for DBP.
In further analyses subjects were di-
vided, according to alcohol consumption,
into drinkers and nondrinkers.
Among nondrinkers (n = 251) the me-
dian B-Pb was 97 pg/l (2.5th and 97.5th
centiles 55-181 pg/l). SBP and DBP aver-
aged 138 ± 17 and 84 ± 9 mm Hg, respec-
tively; in this group no significant
relationship between ln[B-Pb] and both
SBP (r= 0.0014) and DBP (r= -0,0826) was
found.
Among drinkers (n = 1068) the median
B-Pb was 117 pg/l (2.5th and 97.5th cen-
tiles: 63-252 pg/l) and SBP and DBP aver-
aged 141 ± 18 and 84 ± 9 mm Hg,
respectively. In drinkers, the linear correla-
tion between ln[B-Pb] and both SBP (r =
0.1449) and DBP (r= 0.1042) was statisti-
callysignificant (p<0.001); first order regres-
sion coefficient was 7.5 mm Hg/ln(pg/l) for
SBP and 2.6 mm Hg/ln(pg/l) for DBP.
After correction for BMI, AGE, HR, SKF,
serum lipids, CIG/D, and GLU the
adjusted regression coefficients were 5.6
mm Hg/ln(ig/l) for SBP and 2.5 mm
Hg/ln(pg/l) for DBP.
Discussion
In our sample (n = 1319) B-Pb concentra-
tions were significantly higher among sub-
jects with borderline or increased blood
pressure than in subjects with normal
blood pressure. This positive association
was confirmed by a significant direct linear
correlation between B-Pb concentration
and both systolic and diastolic blood pres-
COVARIATES
+8MB +HR +AOE +CIO/D +TRIG +HDL
COVARIATES
Figure 1. Changes of nInB-Pb(pg/l)] coefficient with
successive addition of covariates to a multiple step-
wise regression model analyzing SBP (top) and DBP
(bottom) as dependent variable in male subjects )n=
1319); BMI: body mass index; HR: heart rate; N-HDL:
non-HDL-cholesterol; HDL: HDL-cholesterol; TRIG:
triglycerides; GLUC: glucose; CIG/D: cigarettes smoked
daily; ALC: alcohol consumption; SKF: skinfold
thickness.
sure. The linear regression coefficient was
6.8 mm Hg/ln(ig/l) for SBP and 1.8 mm
Hg/ln(jig/l) for DBP. The entity and the
independence of these relationships were
studied by means of multiple regression
analyses. The partial correlation coefficients
ofsystolic and diastolic blood pressure with
B-Pb concentration remained statistically
significant. Adjusted regression coefficient,
after controlling for age, BMI, heart rate,
serum lipids, glucose levels, smoking, and
skinfold thickness was 5.6 mm Hg/ln(pig/l)
for systolic and 1.7 mm Hg/ln(pg/l) for
diastolic blood pressure.
The highest negative confounding was
due to cigarette consumption. A similar
effect of tobacco use on the blood pres-
sure/B-Pb relationship has been reported
by Sharp et al. (6).
A negative relationship between
tobacco use and blood pressure (18) and a
positive one between smoking and B-Pb
concentration have been previously
described (19). For the cohort under study,
we previously reported (20) that the
median B-Pb concentration was 29.1%
higher in subjects smoking more than 20
cigarettes daily than in nonsmokers.
Moreover, the reported smoking status,
which explained 2.12% of the total vari-
ance, was the second major predictor of
B-Pb concentration (20).
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A positive confounding from alcohol
consumption has been reported by other
authors (12). Various studies have shown a
direct relation between alcohol consump-
tion and both blood pressure (21) and
B-Pb concentration (19,22,23). A highly
significant increase in B-Pb with rising
alcohol consumption has been previously
reported for the subjects examined in the
present survey (20). Alcohol consumption,
explaining 14.71% ofthe total variability,
was by far the most important predictor of
B-Pb concentration; the odds ratio on the
risk ofhaving a B-Pb higher than 180 jig/l
was proportional to the level of alcohol
consumption, with a 27.7-fold increased
risk for heavy drinkers (alcohol intake >100
g/day); B-Pb was more specific and sensi-
tive than HDL-cholesterol and y-glutamyl-
transferase, commonly considered indexes
ofalcohol consumption (24,25), in identi-
fying moderate or heavy drinkers (alcohol
intake >50 g/day), and also showed the
highest positive predictive value.
In spite of these findings, our subjects
alleged alcohol consumption, in contrast
with results obtained in Denmark (12),
failed to alter in a significant manner the
relation between B-Pb and blood pressure.
In our subjects, the highest positive
confounding was due to HDL-cholesterol.
This biochemical indicator ofalcohol con-
sumption (24) decreased the systolic blood
pressure/B-Pb and diastolic blood pres-
sure/B-Pb regression coefficients by 15 and
23%, respectively.
The strong association ofB-Pb concen-
tration to alcohol consumption prompted
us to analyze the B-Pb/blood pressure rela-
tion separately in drinkers and non-
drinkers. Among non-drinkers (n = 251)
- for whom 2.5 and 97.5 centiles of
blood lead distribution were 55 and 181
pg/l, respectively - no significant relation-
ship between B-Pb and both systolic
(r= 0.0014) and diastolic blood pressure
(r= -0.0826) was found.
Among drinkers (n = 1068), for whom
2.5 and 97.5 centiles of B-Pb distribution
63 and 252 pg/l, respectively, the linear
correlation between B-Pb and both systolic
(r = 0.1449) and diastolic blood pressure
(r = 0.1042) was statistically significant
(p <0.001). Linear regression coefficient
was 7.5 mm Hg/ln(pg/l) for SBP and 2.6
mm Hg/ln(pg/l) for DBP. After correction
for body mass index, heart rate, age, HDL-
cholesterol, glucose and skinfold thickness
the adjusted regression coefficients for SBP
was 5.6 mm Hg/ln(pg/l). The adjusted
regression coefficients for DBP, after cor-
rection for body mass index, heart rate, age,
and smoking, was 2.5 mm Hg/ln(pg/l).
In considering our results two main
comments can be made. The first comment
is that B-Pb as a biochemical index ofalco-
hol intake, at least in the absence of occu-
pational exposure, may be a better
indicator ofactual alcohol use than alleged
alcohol consumption (for which voluntary
under-reporting cannot be excluded).
According to this B-Pb would be only an
indicator of alcohol intake and the effect
on blood pressure would be actually due to
alcohol consumption.
The second comment is that low levels
of lead exposure, such as those, mainly
associated to alcohol consumption and
occurring in our subjects (20), might cause
an increase in blood pressure. Animal data
seems to support the hypothesis ofa causal
link. In fact, both in vitro and in vivo
experimental results have strongly sug-
gested a causal relationship between low to
moderate levels of lead exposure and
increases in blood pressure (26-28).
In conclusion, the adjusted regression
coefficient between ln[B-Pb] and blood
pressure we have found among drinkers
represents an increment of about 6 and 3
mm Hg in systolic and diastolic blood
pressure over the range of observed B-Pb
levels (i.e., 40-442 pg/1). In terms of a
slope of2 mm Hg for a 100 pg/l change in
B-Pb, the decline in B-Pb concentration of
about 100 pg/l we have observed in male
subjects living in the Rome area since 1979
(20), although not producing significant
changes in the relative risk ofcardiovascu-
lar disease, might have some importance
from a public health perspective.
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